| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 139, 1131-1142, Copyright © 1991 by American Society for Investigative Pathology
REGULAR ARTICLES |
B Bhambi and M Eghbali
Cardiovascular Institute, Michael Reese Hospital, Chicago, IL 60616.
Biosynthesis of the collagen matrix of the heart has been shown to be regulated under various physiologic and pathologic conditions. Biogenic amines have known effects on myocardial function. The authors studied the effects of norepinephrine on myocardial collagen gene expression in the rat heart. Norepinephrine was administered intravenously in a sustained-release manner. Within 1 hour after treatment, the abundance of mRNA for pro alpha 2 (I) collagen increased by 212% (P = 0.05), TGF- beta 1 by 91% (P = 0.05), and cytoskeletal actin by 429% (P less than 0.01) in the ventricular myocardium of the treated rats compared with that in control untreated rats. In extended period of treatment, the abundance of mRNA for pro alpha 2 (I) collagen reached a peak (206% increase, P less than 0.01) at day 3, remained elevated through day 6, and returned to the control levels at 2 weeks after treatment. The expression of mRNA for TGF-beta 1 was coregulated with that of pro alpha 2 (I) collagen. The abundance of mRNA for cytoskeletal actin showed a sharp increase (323%, P less than 0.05) at day 1 and remained elevated through day 6 in treated hearts compared with that in control hearts and returned to the control levels at 2 weeks after treatment. Coadministration of alpha-receptor blocker, phentolamine, led to modest reversal, whereas coadministration of beta-receptor blocker, propranolol, led to about 50% reversal of norepinephrine effects on the abundance of mRNAs. At day 3 of treatment, collagen content of ventricular tissue, as determined by hydroxyproline measurement was increased by 13% (P less than 0.05) in treated hearts. Immunofluorescent light microscopy showed increased collagen deposition and focal areas of necrosis in the endocardial regions in hearts of animals treated with norepinephrine for 2 weeks. In vitro studies on cultured cardiac fibroblasts showed that although norepinephrine treatment does not lead to significant changes in the abundance of mRNA for pro alpha 2 (I) collagen, it leads to increased mRNA for cytoskeletal actin and increased (113%, P less than 0.05) 3H-thymidine incorporation into the cell nuclei of treated cells compared with that in untreated cells. The authors conclude that although norepinephrine has no direct in vitro effects on collagen type I biosynthesis, its in vivo effects may lead to a cascade of events such as induction of growth factors that ultimately result in increased expression of collagen type I in the myocardium.
This article has been cited by other articles:
 |
|
 |
|
  T. Soeki, I. Kishimoto, D. O. Schwenke, T. Tokudome, T. Horio, M. Yoshida, H. Hosoda, and K. Kangawa Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H426 - H432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Avila, I. M. Medina, E. Jimenez, G. Elizondo, and C. I. Aguilar Transforming growth factor-beta1 decreases cardiac muscle L-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H622 - H631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Shigeyama, Y. Yasumura, A. Sakamoto, Y. Ishida, T. Fukutomi, M. Itoh, K. Miyatake, and M. Kitakaze Increased gene expression of collagen Types I and III is inhibited by {beta}-receptor blockade in patients with dilated cardiomyopathy Eur. Heart J., December 2, 2005; 26(24): 2698 - 2705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Briest, L. Homagk, B. Rassler, B. Ziegelhoffer-Mihalovicova, H. Meier, A. Tannapfel, S. Leiblein, A. Saalbach, A. Deten, and H.-G. Zimmer Norepinephrine-Induced Changes in Cardiac Transforming Growth Factor-{beta} Isoform Expression Pattern of Female and Male Rats Hypertension, October 1, 2004; 44(4): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A Turner, K. E Porter, W. H.T Smith, H. L White, S. G Ball, and A. J Balmforth Chronic {beta}2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism Cardiovasc Res, March 1, 2003; 57(3): 784 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rosenkranz, M. Flesch, K. Amann, C. Haeuseler, H. Kilter, U. Seeland, K.-D. Schluter, and M. Bohm Alterations of beta -adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta 1 Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1253 - H1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Akiyama-Uchida, N. Ashizawa, A. Ohtsuru, S. Seto, T. Tsukazaki, H. Kikuchi, S. Yamashita, and K. Yano Norepinephrine Enhances Fibrosis Mediated by TGF-{beta} in Cardiac Fibroblasts Hypertension, August 1, 2002; 40(2): 148 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Leicht, W. Briest, A. Holzl, and H.-G. Zimmer Serum depletion induces cell loss of rat cardiac fibroblasts and increased expression of extracellular matrix proteins in surviving cells Cardiovasc Res, December 1, 2001; 52(3): 429 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Varagic, D. Susic, and E. D. Frohlich Cardiovasc Pharmacol Therapeut 6(1):57-63, 2001 Low-Dose ACE with Alphaor Beta-Adrenergic Receptor Inhibitors Have Beneficial SHR Cardiovascular Effects Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 57 - 63. [Abstract] [PDF]
|
|
|
|
|
|
M. Leicht, N. Greipel, and H.-G. Zimmer Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture Cardiovasc Res, November 1, 2000; 48(2): 274 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Thomas, S. D. Zimmerman, T. R. Hansen, D. T. Martin, and R. J. McCormick Collagen gene expression in rat left ventricle: interactive effect of age and exercise training J Appl Physiol, October 1, 2000; 89(4): 1462 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Schwartzkopff, M. Brehm, M. Mundhenke, and B. E. Strauer Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease Hypertension, August 1, 2000; 36(2): 220 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wei, L. T. C. Chow, and J. E. Sanderson Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction J. Am. Coll. Cardiol., July 1, 2000; 36(1): 276 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Bishop and G. Lindahl Regulation of cardiovascular collagen synthesis by mechanical load Cardiovasc Res, April 1, 1999; 42(1): 27 - 44. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Koudssi, J. E. Lopez, S. Villegas, and C. S. Long Cardiac Fibroblasts Arrest at the G1/S Restriction Point in Response to Interleukin (IL)-1beta . EVIDENCE FOR IL-1beta -INDUCED HYPOPHOSPHORYLATION OF THE RETINOBLASTOMA PROTEIN J. Biol. Chem., October 2, 1998; 273(40): 25796 - 25803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Zheng, L. O'Neill, X. Long, T. E Webb, E. A Barnard, E. G Lakatta, and M. O Boluyt Stimulation of P2Y receptors activates c-fos gene expression and inhibits DNA synthesis in cultured cardiac fibroblasts Cardiovasc Res, March 1, 1998; 37(3): 718 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J E Sanderson, S K W Chan, C M Yu, L Y C Yeung, W M Chan, K Raymond, K W Chan, and K S Woo beta Blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol Heart, January 1, 1998; 79(1): 86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Stilli, B. Aimi, A. Sgoifo, P. Ciarlini, G. Regoliosi, C. Lagrasta, G. Olivetti, and E. Musso Dependence of temporal variability of ventricular recovery on myocardial fibrosis. Role of mechanoelectric feedback? Cardiovasc Res, January 1, 1998; 37(1): 58 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Sun and Y.-C. Ng Effects of norepinephrine on expression of IGF-1/IGF-1R and SERCA2 in rat heart Cardiovasc Res, January 1, 1998; 37(1): 202 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ohta, S. Kim, and H. Iwao Role of Angiotensin-Converting Enzyme, Adrenergic Receptors, and Blood Pressure in Cardiac Gene Expression of Spontaneously Hypertensive Rats During Development Hypertension, October 1, 1996; 28(4): 627 - 634. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Farivar, D. C. Crawford, A. V. Chobanian, and P. Brecher Effect of Angiotensin II Blockade on the Fibroproliferative Response to Phenylephrine in the Rat Heart Hypertension, April 1, 1995; 25(4): 809 - 813. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
